Picture of AnaptysBio logo

ANAB AnaptysBio Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual balance sheet for AnaptysBio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments248427374394548
Net Total Receivables1.60.17400.876
Prepaid Expenses
Total Current Assets253434378397554
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.6651.453.022.1321.8
Long Term Investments
Other Long Term Assets
Total Assets329509435417643
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities14.121.829.519.816.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities21.822.630.219.8287
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity308486405397356
Total Liabilities & Shareholders' Equity329509435417643
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email